Preserving US microbe collections sparks future discoveries.

Collections of micro-organisms are a crucial element of life science research infrastructure but are vulnerable to loss and damage caused by natural or man-made disasters, the untimely death or retirement of personnel, or the loss of research funding. Preservation of biological collections has risen in priority due to a new appreciation for discoveries linked to preserved specimens, emerging hurdles to international collecting and decreased funding for new collecting. While many historic collections have been lost, several have been preserved, some with dramatic rescue stories. Rescued microbes have been used for discoveries in areas of health, biotechnology and basic life science. Suggestions for long-term planning for microbial stocks are listed, as well as inducements for long-term preservation.

Casts of Fluid Preserved Specimens.

Previous writings in the area of natural history casting are exiguous especially in reference to the casting of fluid preserved specimens. The following attempts to recognize the importance of casts as natural history specimens and determine why this method of preservation might be used. This piece goes on to instruct the reader how to create their own casts using a simple method and materials which are readily available to all.

Photographing Fluid-Preserved Specimens.

There is an important trend among museums and universities to digitize their collections both to help with archiving and allow remote access to their specimens (Olsen Museum specimens find new life online. The New York Times, 2015). While taxidermied animals, casts, and insect samples can be positioned and lit relatively easily, those that are preserved and stored in glass or Perspex jars need special lighting and a carefully thought out studio in order to get the best images. The photographs then need to be archived and stored to avoid loss. Many institutions are seeking to prepare 3D images, but this does not work for specimens contained with transparent vessels. In this chapter, we describe our approach to photography of fluid-preserved specimens.

Exploring dry storage as an alternative biobanking strategy inspired by Nature.

Biobanking is a rapidly growing industry, covering diverse fields such as human medicine, farm animal production, laboratory animals record keeping, and wildlife conservation. Presently, biobanking is done almost exclusively by cryopreservation, followed by maintenance of the samples under liquid nitrogen. Cryopreservation has satisfactory efficiency but it comes with a host of problems, and the process is highly species-specific. Like in many other walks of life, we turn to Nature in search for better alternatives. Nature opted for controlled drying rather than water preservation via freezing when long-term preservation is desired, a strategy known as 'anhydrobiosis'. To achieve reversible drying, anhydrobiotic organisms utilise an assortment of protective materials, including disaccharides, late embryogenesis abundant proteins, anhydrin, heat shock protein, and more. Once dry, desiccation-tolerant organisms can survive extended periods of time and be resistant to extreme environmental stressors. Over the past 70 years researchers attempted applying this idea to preserve desiccation-sensitive mammalian cells in the dry form. At present dried cells mostly do not resume biological activity upon rehydration. The DNA, however, is often well preserved to allow utilisation in advanced reproductive techniques. Spermatozoa are by far the most commonly dried cell type, primarily from mice and bulls. A number of drying approaches have been applied, with freeze-drying taking the lead. To date offspring have been produced from dried spermatozoa in mouse, rat, hamster, rabbit, and horse. No offspring were produced from dried somatic cells. Desiccation experiences a sharp increase in interest and research output in recent years. Presented here is an overview of dry preservation, its possible applications, the open questions the field is still facing, and some suggested directions for the future.

Cellular lifespan and regenerative medicine.

Tissue engineering is a promising approach to aid in the treatment of a wide range of clinical disorders by developing replacement tissues for damaged or diseased organs. Such approaches, however, will require large and functional cell populations in order to produce a tissue that can replicate in vivo function. Most adult cells have limited replicative potential that limits their use in tissue engineering applications. Thus, cell populations with expanded lifespan or increased replicative potential are of interest. Stem cell-derived populations may allow the creation of large cell populations that have increased replicative potential over adult differentiated cells. In addition, ectopic human telomerase reverse transcriptase expression and induced B-cell lymphoma 2 (bcl-2) expression can allow adult cells to proliferate more extensively than unaltered cells. However, concerns for malignant transformation exist with telomerase and bcl-2 approaches. The current states of research in these areas are reviewed as they relate to tissue engineering and the cellular lifespan.

Update on multi-center clinical trials in the United States.

This article reviews numerous multi-center clinical trials, either ongoing or in planning stages, which involve diverse clinical applications and emerging technologies in apheresis and transfusion medicine. The investigations summarized herein involve the following specific areas: platelet dosing strategy, thrombotic thrombocytopenia purpura, inflammatory bowel disease, seven-day platelet storage, dendritic cell vaccines, and age-related macular degeneration.

Recent achievements in in vitro culture and preservation of ovarian follicles in mammals.

The mammalian ovary contains a large number of follicles that are in various developmental stages. The largest portion of them are primordial follicles. However, throughout the female reproductive lifespan only a small proportion of these follicles will produce oocytes competent to undergo successful maturation and ovulation. The rest of the ovarian oocytes (>99.9%) undergo atresia. It would be of great practical benefit to rescue some of these follicles by growing them in culture in order to provide an extra source of gametes. There is considerable interest in developing technologies that aim to produce fully-grown, developmentally competent oocytes from a pool of early developmental stages of follicles. Two methods have been used: 1/ long-term in vitro culture of either follicles or oocytes, and 2/ transplantation of ovarian tissue grafts. The development of efficient technologies may provide an additional source of oocytes for livestock production and reproduction in humans and rare or endangered species. The aim of this paper is to present a comprehensive review of recent achievements in the utilization of small ovarian follicles (primordial, preantral and early antral) by long-term in vitro culture and/or transplantation of ovarian tissue grafts (fresh and cryopreserved) in mammals including humans.

Biopreservation of red blood cells: past, present, and future.

Preservation and long-term storage of red blood cells (RBCs) is needed to ensure a readily available, safe blood supply for transfusion medicine. Effective preservation procedures are required at various steps in the production of a RBC product including testing, inventory, quality control, and product distribution. Biopreservation is the process of maintaining the integrity and functionality of cells held outside the native environment for extended storage times. The biopreservation of RBCs for clinical use can be categorized based on the techniques used to achieve biologic stability and ensure a viable state after long-term storage. This paper will review the history, science, current practices, and emerging technologies of current RBC biopreservation approaches: hypothermic storage, cryopreservation, and lyophilization.

DNA book.

We propose herein a new method of DNA distribution, whereby DNA clones or PCR products are printed directly onto the pages of books and delivered to users along with relevant scientific information. DNA sheets, comprising water-soluble paper onto which DNA is spotted, can be bound into books. Readers can easily extract the DNA fragments from DNA sheets and amplify them using PCR. We show that DNA sheets can withstand various conditions that may be experienced during bookbinding and delivery, such as high temperatures and humidity. Almost all genes (95%-100% of randomly selected RIKEN mouse cDNA clones) were recovered successfully by use of PCR. Readers can start their experiments after a 2-h PCR amplification without waiting for the delivery of DNA clones. The DNA Book thus provides a novel method for delivering DNA in a timely and cost-effective manner. A sample DNA sheet (carrying RIKEN mouse cDNA clones encoding genes of enzymes for the TCA cycle) is included in this issue for field-testing. We would greatly appreciate it if readers could attempt to extract DNA and report the results and whether the DNA sheet was shipped to readers in good condition.